Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
0.00
(0.00%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences surges on getting final approval from USFDA for Lacosamide Injection
>>
Zydus Lifesciences gets final approval from USFDA for Lacosamide Injection
>>
Zydus Lifesciences informs about newspaper publication
>>
Zydus Lifesciences informs about buyback offer
>>
Zydus Lifesciences informs about appointment of chairman as time non-official director in RBI
>>
Zydus Lifesciences to commence Rs 750 crore share buyback offer on June 23
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences gets final approval from USFDA for Adapalene and Benzoyl Peroxide Topical Gel
>>
Zydus Lifesciences informs about investor conference
>>
Zydus Lifesciences inches up on getting USFDA’s final nod for Famotidine Tablets
<<
<
63
64
65
...168
>
>>